120 related articles for article (PubMed ID: 25719312)
1. SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A.
Xu W; Jiang K; Shen M; Qian Y; Peng Y
Biol Chem; 2015 Aug; 396(8):929-36. PubMed ID: 25719312
[TBL] [Abstract][Full Text] [Related]
2. miR‑150 promotes the proliferation and migration of non‑small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.
Jiang K; Shen M; Chen Y; Xu W
Oncol Rep; 2018 Aug; 40(2):943-951. PubMed ID: 29901178
[TBL] [Abstract][Full Text] [Related]
3. Regulation of SIRT2 levels for human non-small cell lung cancer therapy.
Li Z; Xie QR; Chen Z; Lu S; Xia W
Lung Cancer; 2013 Oct; 82(1):9-15. PubMed ID: 23915912
[TBL] [Abstract][Full Text] [Related]
4. Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
Xu W; Jiang K; Shen M; Chen Y; Huang HY
Oncol Rep; 2016 Jan; 35(1):352-8. PubMed ID: 26498874
[TBL] [Abstract][Full Text] [Related]
5. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
[TBL] [Abstract][Full Text] [Related]
6. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
[TBL] [Abstract][Full Text] [Related]
7. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.
Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW
Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696
[TBL] [Abstract][Full Text] [Related]
8. Sirt2 suppresses glioma cell growth through targeting NF-κB-miR-21 axis.
Li Y; Dai D; Lu Q; Fei M; Li M; Wu X
Biochem Biophys Res Commun; 2013 Nov; 441(3):661-7. PubMed ID: 24161395
[TBL] [Abstract][Full Text] [Related]
9. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2015; 8(4):3827-34. PubMed ID: 26097565
[TBL] [Abstract][Full Text] [Related]
10. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
11. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
Huang J; Sun C; Wang S; He Q; Li D
Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑361‑5p suppresses cancer progression by targeting signal transducer and activator of transcription 6 in non‑small cell lung cancer.
Ma Y; Bao C; Kong R; Xing X; Zhang Y; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Zhang D; Ma Z; Sun L; Zhou B
Mol Med Rep; 2015 Nov; 12(5):7367-73. PubMed ID: 26461141
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
15. Involvement of p29/SYF2/fSAP29/NTC31 in the progression of NSCLC via modulating cell proliferation.
Liu Y; Ni T; Xue Q; Lv L; Chen B; Cui X; Cui Y; Wang Y; Mao G; Ji L
Pathol Res Pract; 2015 Jan; 211(1):36-42. PubMed ID: 25433998
[TBL] [Abstract][Full Text] [Related]
16. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
Wu DW; Cheng YW; Wang J; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.
Ke Y; Zhao W; Xiong J; Cao R
FEBS Lett; 2013 Sep; 587(18):3153-7. PubMed ID: 23954293
[TBL] [Abstract][Full Text] [Related]
18. MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.
Shi H; Ji Y; Zhang D; Liu Y; Fang P
Biochem Biophys Res Commun; 2015 Sep; 465(1):125-30. PubMed ID: 26235874
[TBL] [Abstract][Full Text] [Related]
19. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection.
Walker T; Nolte A; Steger V; Makowiecki C; Mustafi M; Friedel G; Schlensak C; Wendel HP
Eur J Cardiothorac Surg; 2013 Mar; 43(3):628-33; discussion 633-4. PubMed ID: 23152437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
